Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/5/23 → 03/29/26 |
Funding
- QOL Medical LLC: $40,813.50
Evaluation of a 7-Day Therapeutic Trial Dose of Commercial Sucraid (sacrosidase) Oral Solution for Alleviating Congenital Sucrase-Isomaltase Deficiency (CSID) Symptoms in Pediatric Subjects with Low, Moderate, and Normal Sucrase Levels
- Small-Harary, Lesley (PI)
- Breglio, Keith (CoPI)
- Chawla, Anupama (CoPI)
- Gathungu, Grace (CoPI)
- Lee, Ada (CoPI)
- Morganstern, Jeffrey (CoPI)
- Tobin, Michelle (CoPI)
Project: Research